Updated: July 2, 2024
Initiative
Naloxone
Contractor
Emergent Devices, Inc.
Total Amount for Initiative
$4,250,000 over two years
Number of Awards
1
Overview
Through this contract with Emergent Devices, Inc., the New York State Department of Health AIDS Institute purchases Narcan®, a 4mg intranasal formulation of naloxone. This medication reverses potentially fatal opioid overdoses and has been successfully deployed in the community among more than 700,000 non-medical persons. These “citizen responders” are trained by more than 1,200 New York State Department of Health registered Opioid Overdose Prevention Programs to recognize overdoses and to respond to them by calling emergency medical services and administering Narcan. Naloxone is central to the State’s response to the opioid overdose crisis.